ResearchDx , Leading Personalized Medicine And Contract Diagnostics Organization To Attend San Francisco Conference
International Molecular Medicine Tri-Conference Welcomes Noted
Irvine Companion Diagnostics Company
Irvine, CA February 10, 2015 – ResearchDx, Inc. of Irvine, California will exhibit at the 22nd International Molecular Medicine Tri-Conference in San Francisco, CA at Moscone North Convention Center on February 15-20, 2015. Over 3000 attendees from over 40 countries will attend and take part in the 400+ presentations and panel discussions.
The 6-day event on molecular medicine will focus on drug discovery, genomics, diagnostics and information technology. Attendees gain insight and knowledge that can impact their research and drive change in working towards shaping the future of medicine
“Personalized medicine is increasing in importance and a critical adjunct is the availability of suitable companion diagnostic assays used to stratify patients for eligibility for a particular drug, monitor disease status or used to determine drug dosage,” said Dr. Philip Cotter, Principal and Co-Founder of ResearchDx. “Regulatory agencies have indicated the desirability of co-developing pharmaceuticals and associated companion diagnostic assays. We provide a flexible, integrated service to pharmaceutical companies wanting to outsource companion diagnostic assay development. We offer consulting, assay development, assay kit manufacture, clinical trial management and regulatory services and a Clinical Laboratory. The combination of these services allows outsourcing of the complete companion diagnostic development process to a single business partner, ResearchDx.”
The direction for ResearchDX at the conference will be on providing services for the growing clinical laboratory and diagnostics markets. A Contract Diagnostics Organization (CDO), ResearchDX was formed in 2008. The Consulting Services Division of ResearchDx provides comprehensive Clinical Laboratory consulting services encompassing quality management systems; assay design, validation and implementation; and consulting for CLIA and International CLIA certification, State licensures, and Joint Commission International, College of American Pathologists, and ISO 15189 accreditations.
“As the leading Contract Diagnostics Organization, ResearchDx can provide strategic partnerships to biopharmaceutical and diagnostic companies looking to develop companion diagnostics or in vitro diagnostic products for the local, US or European markets. We provide a full range of companion diagnostics and in vitro diagnostics services,” said Dr. Mathew Moore, Principal and Co-Founder of ResearchDx.
ResearchDx is the leading Contract Diagnostics Organization serving the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, and flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization, and validation in a CAP/CLIA laboratory environment through a complete set of clinical research services and regulatory approval, ResearchDx offers solutions to meet customers’ complex needs in diagnostics development. ResearchDx’s primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting. Additional information is available at www.researchdx.com.
###
Media Contact:
Philip D. Cotter, PhD, FACMG, FFSc(RCPA)
ResearchDx
5 Mason, Suite 100
Irvine, CA 92618
pcotter@researchdx.com
866-225-9195 / 510-332-0477
Help employers find you! Check out all the jobs and post your resume.
Irvine, CA February 10, 2015 – ResearchDx, Inc. of Irvine, California will exhibit at the 22nd International Molecular Medicine Tri-Conference in San Francisco, CA at Moscone North Convention Center on February 15-20, 2015. Over 3000 attendees from over 40 countries will attend and take part in the 400+ presentations and panel discussions.
The 6-day event on molecular medicine will focus on drug discovery, genomics, diagnostics and information technology. Attendees gain insight and knowledge that can impact their research and drive change in working towards shaping the future of medicine
“Personalized medicine is increasing in importance and a critical adjunct is the availability of suitable companion diagnostic assays used to stratify patients for eligibility for a particular drug, monitor disease status or used to determine drug dosage,” said Dr. Philip Cotter, Principal and Co-Founder of ResearchDx. “Regulatory agencies have indicated the desirability of co-developing pharmaceuticals and associated companion diagnostic assays. We provide a flexible, integrated service to pharmaceutical companies wanting to outsource companion diagnostic assay development. We offer consulting, assay development, assay kit manufacture, clinical trial management and regulatory services and a Clinical Laboratory. The combination of these services allows outsourcing of the complete companion diagnostic development process to a single business partner, ResearchDx.”
The direction for ResearchDX at the conference will be on providing services for the growing clinical laboratory and diagnostics markets. A Contract Diagnostics Organization (CDO), ResearchDX was formed in 2008. The Consulting Services Division of ResearchDx provides comprehensive Clinical Laboratory consulting services encompassing quality management systems; assay design, validation and implementation; and consulting for CLIA and International CLIA certification, State licensures, and Joint Commission International, College of American Pathologists, and ISO 15189 accreditations.
“As the leading Contract Diagnostics Organization, ResearchDx can provide strategic partnerships to biopharmaceutical and diagnostic companies looking to develop companion diagnostics or in vitro diagnostic products for the local, US or European markets. We provide a full range of companion diagnostics and in vitro diagnostics services,” said Dr. Mathew Moore, Principal and Co-Founder of ResearchDx.
ResearchDx is the leading Contract Diagnostics Organization serving the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, and flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization, and validation in a CAP/CLIA laboratory environment through a complete set of clinical research services and regulatory approval, ResearchDx offers solutions to meet customers’ complex needs in diagnostics development. ResearchDx’s primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting. Additional information is available at www.researchdx.com.
###
Media Contact:
Philip D. Cotter, PhD, FACMG, FFSc(RCPA)
ResearchDx
5 Mason, Suite 100
Irvine, CA 92618
pcotter@researchdx.com
866-225-9195 / 510-332-0477
Help employers find you! Check out all the jobs and post your resume.